Loading...
A Randomized, Double‐Blind, Placebo‐Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss
OBJECTIVE: This study aims to assess the efficacy and safety of Gelesis100, a novel, nonsystemic, superabsorbent hydrogel to treat overweight or obesity. METHODS: The Gelesis Loss Of Weight (GLOW) study was a 24‐week, multicenter, randomized, double‐blind, placebo‐controlled study in patients with B...
Na minha lista:
| Udgivet i: | Obesity (Silver Spring) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587502/ https://ncbi.nlm.nih.gov/pubmed/30421844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.22347 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|